News
Trident Texofab standalone net profit declines 49.02% in the June 2026 quarter
11-Aug-2026 | 07:30
Sales decline 6.91% to Rs 26.14 crore
Net profit of Trident Texofab declined 49.02% to Rs 0.52 crore in the quarter ended June 2026 as against Rs 1.02 crore during the previous quarter ended June 2025. Sales declined 6.91% to Rs 26.14 crore in the quarter ended June 2026 as against Rs 28.08 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 26.14 | 28.08 | -7 |
| OPM % | 5.43 | 7.37 | - |
| PBDT | 1.06 | 1.78 | -40 |
| PBT | 0.68 | 1.37 | -50 |
| NP | 0.52 | 1.02 | -49 |
Powered by Capital Market - Live News